USPSTF 2024: screening and supplementation for iron deficiency in pregnancy
A 2024 statement from the US Preventive Services Task Force on iron in healthy pregnancy. It says the evidence is not enough to judge the benefits and harms of screening for iron deficiency, or of routine iron supplements, in pregnant people without symptoms.
- Guideline
- In this atlas
Overview
Technical summary
USPSTF recommendation statement, JAMA 2024, volume 332, issue 11 (PubMed issue date 2024-09-17). Both conclusions are I statements, recorded as claims on the iron page. Whether a later edition exists was not checked. The guideline's source is the USPSTF final recommendation statement page, which gives the statement date that the recommendation decisions use; the JAMA statement stays cited in the claims.
About this guideline
- Issued by
- Edition
- USPSTF final recommendation statement, as shown on its page; also published as: Recommendation statement, JAMA 2024;332(11)
- Published
- 2024-08-20
- Status
- Not checked for a newer edition
- Scope
- Asymptomatic pregnant adolescents and adults
Source
- Document
- Iron Deficiency and Iron Deficiency Anemia During Pregnancy: Screening and Supplementation (USPSTF final recommendation statement page)
- Publisher
- U.S. Preventive Services Task Force
- Edition note
- Final recommendation statement page as fetched on 2026-10-14 (mx-uspstf-iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation.html). The date under the title is August 20, 2024.
Recommendations
- Evidence is insufficient to recommend for or against: Iron supplementation and iron screening in pregnancy
- Evidence is insufficient to recommend for or against: Iron supplementation and iron screening in pregnancy
Record details
- Record id
maternal:guideline-uspstf-2024-iron-pregnancy- Content hash
2e5695556daf55c381a844cde63a6cda365d3f30c76417ed0122f83e019e975a